Atm is a negative regulator of intestinal neoplasia

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The ataxia-telangiectasia-mutated (ATM) gene is recognized for its role in tumor suppression.
• ATM's function as an early barrier to solid tumor growth and progression is under investigation.

Purpose of the Study:

• To investigate the role of the mouse Atm gene in the early stages of intestinal tumor development.
• To determine if Atm deficiency impacts tumor growth and multiplicity in established models of familial colon cancer.

Main Methods:

• Utilized two distinct mouse models of familial colon cancer: Apc(Min/+) and Apc(1638N/+).
• Assessed the impact of germ-line nullizygosity for the mouse Atm gene on tumor proliferative index, net growth rate, and multiplicity.
• Compared the effects of Atm deficiency with deficiencies in Bloom's syndrome helicase and DNA ligase 4.
• Evaluated the independence of Atm loss effects from ionizing radiation and its impact on loss of heterozygosity rates at the Apc locus.

Main Results:

• Germ-line Atm deficiency significantly increased the proliferative index, net growth rate, and multiplicity of intestinal adenomas in both Apc(Min/+) and Apc(1638N/+) models.
• The effects of Atm deficiency on tumor multiplicity were quantitatively distinct from deficiencies in Bloom's syndrome helicase or DNA ligase 4.
• The impact of Atm loss on tumor multiplicity was largely independent of ionizing radiation exposure.
• Loss of heterozygosity rates at the Apc locus remained unaffected by Atm loss.

Conclusions:

• The Atm gene product acts as a barrier to dysplastic growth during the early stages of intestinal tumor progression.
• This barrier function of ATM is independent of its known roles in maintaining genomic stability.
• Targeting ATM may offer therapeutic strategies for early-stage intestinal cancers.